Dear Colleagues,
Numerous studies and technologies exist to improve and accelerate antibody development, and new approaches are constantly being explored to improve antibody properties. Yet challenges in the discovery and development of the next generation of antibody drugs remain.
GTCBio’s Antibody Partnering & Technology Summit, to be held this October 29-30, 2009 in San Francisco, CA, will provide a unique look at the antibody field while the balancing equally business (e.g., M&A) and R&D-related content. This exclusive antibody partnering conference was specifically designed to provide an intimate environment for those who want to network and collaborate with high-level executives. You will meet with top companies who are dynamically seeking scientific and business tactics that will accelerate antibody drug discovery and development. Without a doubt, this novel, hybrid-content conference will augment your opportunities for successful partnering and deal-making in 2010 and beyond.
The conference features the following sessions & panel discussions:
I: The Effect of Biosimilars: Roadmap to the Future
Panel Discussion: The Effect of Biosimilars: Roadmap to the Future
II: Opportunities for Antibody Partnering and Licensing
Panel Discussion: Opportunities for Antibody Partnering and Licensing
III: Antibody Mergers and Acquisitions
Panel Discussion: Antibody Merges and Acquisitions
IV: Novel and Next Generation Antibody Technologies
Panel Discussion: Novel and Next Generation Antibody Technologies
Interactive Panel Discussions
What the Partners are Looking for in Antibodies?
Antibody Platform Menagerie Panel (Mouse, Chicken, Shark & Camel)
The summit will also provide a forum for participants to:
-
Learn about the latest advances in antibody partnering and technology
-
Explore potential collaborations
-
Gain insights from industry decision makers as they share their thoughts on market trends and forecast for the next decade
We look forward to seeing you at the summit!
Best regards,
- 2009 Conference Advisory Committee